Issues related to organ transplants; Medicare issues relevant to pharmaceutical companies
2026 · 3rd Quarter (July 1 - Sep 30)
HANSA BIOPHARMA AB
Filed by JEFFREY J. KIMBELL & ASSOCIATES, INC..
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Oct 11, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- JEFFREY J. KIMBELL & ASSOCIATES, INC.
- Client
- HANSA BIOPHARMA AB
- Filing UUID
- 8b9217d4-64ee-4f63-9049-a8bb0ca0c0f4
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to organ transplants; Medicare issues relevant to pharmaceutical companies
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.